Join the High Cholesterol group to help and get support from people like you.
High Cholesterol News (Page 2)
Related terms: Cholesteremia, Cholesterol, Elevated Levels, Cholesterol, High, Cholesterolemia, Familial Hypercholesterolemia, Hypercholesterolemia, Hypercholesterolemia, Familial, Hyperlipidemia, Lipid Metabolism Disorders
AHA: Muvalaplin Reduces Lipoprotein(a) Levels in Individuals With Cardiovascular Risk
MONDAY, Nov. 25, 2024 – Muvalaplin reduces lipoprotein(a) levels, according to a study published online Nov. 20 in the Journal of the American Medical Association to coincide with the American Heart...
Prevalence of High Total Cholesterol 11.3 Percent in U.S. Adults
WEDNESDAY, Nov. 20, 2024 – The prevalence of high total cholesterol was 11.3 percent among U.S. adults in August 2021 to August 2023, according to a November data brief published by the National...
About 1 in 10 U.S. Adults Have High Cholesterol
WEDNESDAY, Nov. 20, 2024 – Nearly 1 in every 10 American adults is living with high levels of cholesterol in their arteries, according to the latest report from the U.S. Centers for Disease Control...
Small but Important Differences Seen Between Rosuvastatin, Atorvastatin
WEDNESDAY, Oct. 30, 2024 – There are small but important differences in risk for some clinical outcomes associated with rosuvastatin and atorvastatin, according to a study published online Oct. 29...
Study Reveals No Link Between HDL Cholesterol and Movement Disorders
FRIDAY, Sept. 20, 2024 – There is no correlation between high-density lipoprotein cholesterol (HDL-C) levels and a patient's risk for developing movement disorders while taking an antipsychotic, a...
Statin Therapy Cost-Effectively Improves Health Outcomes for ≥70s
THURSDAY, Sept. 12, 2024 – Statin therapy improves health outcomes and is cost-effective for men and women aged 70 years and older, according to a study published online Sept. 10 in Heart. Borislava...
Inflammation, Cholesterol, Lipoprotein(a) Predict 30-Year Cardiovascular Outcomes in Women
TUESDAY, Sept. 3, 2024 – A single combined measure of high-sensitivity C-reactive protein (CRP), low-density lipoprotein (LDL) cholesterol, and lipoprotein(a) levels predict the 30-year risk for...
Menopausal Transition Linked to Adverse Changes in Lipoprotein Profile
FRIDAY, Aug. 30, 2024 – Menopausal status is associated with adverse changes in lipoprotein profiles, according to a study presented at the European Society of Cardiology Congress 2024, held from...
Cholesterol Could Be Link Between Menopause and Heart Disease
TUESDAY, Aug. 27, 2024 – During menopause, a woman’s blood cholesterol changes in a way that could harm her heart health, a new study warns. An increase in “bad” LDL cholesterol and a decrease in “go...
Fish Oil Supplements Counteract Genetic Predisposition to High Cholesterol
WEDNESDAY, Aug. 14, 2024 – Fish oil seems to counteract genetic predisposition to high cholesterol, according to a study published online July 15 in the American Journal of Clinical Nutrition. ...
Fish Oil Might Help Keep Cholesterol in Check
THURSDAY, Aug. 8, 2024 – People with a genetic predisposition for high cholesterol can lower their levels by taking fish oil supplements, a new study shows. The results indicate that lifestyle can...
Cholesterol Absorption Inhibitors May Cut Risk for Liver Cancer
WEDNESDAY, July 31, 2024 – The use of cholesterol absorption inhibitors is associated with a reduced risk for liver cancer, according to a study published online July 29 in Cancer. Shahriar A. ...
Can Non-Statin Cholesterol Meds Help Your Liver?
WEDNESDAY, July 31, 2024 – Prior studies have found that statin meds can help lower liver cancer risks, and new research suggests that at least one non-statin cholesterol drug can do the same. A...
Plozasiran Reduces Triglyceride Levels in Mixed Hyperlipidemia
MONDAY, June 3, 2024 – For individuals with mixed hyperlipidemia, plozasiran reduces triglyceride levels at 24 weeks, according to a study published online May 28 in the New England Journal of...
U.S. FDA Approves Broad New Labels for Nexletol and Nexlizet to Prevent Heart Attacks and Cardiovascular Procedures in Both Primary and Secondary Prevention Patients, Regardless of Statin Use
ANN ARBOR, Mich., March 22, 2024 (GLOBE NEWSWIRE) – Esperion (NASDAQ: ESPR) today announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for...
Further information
Related condition support groups
High Cholesterol - Familial Heterozygous, High Cholesterol - Familial Homozygous, Cardiovascular Conditions and Disorders
Related drug support groups
atorvastatin, simvastatin, Repatha, Crestor, pravastatin, Zetia, ezetimibe, cholestyramine, niacin, rosuvastatin, garcinia cambogia, Leqvio, garlic